↓ Skip to main content

Outcome of peptide receptor radionuclide therapy with 177Lu-octreotate in advanced grade 1/2 pancreatic neuroendocrine tumours

Overview of attention for article published in European Journal of Nuclear Medicine and Molecular Imaging, February 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (89th percentile)
  • High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

policy
2 policy sources
patent
2 patents

Citations

dimensions_citation
167 Dimensions

Readers on

mendeley
87 Mendeley
Title
Outcome of peptide receptor radionuclide therapy with 177Lu-octreotate in advanced grade 1/2 pancreatic neuroendocrine tumours
Published in
European Journal of Nuclear Medicine and Molecular Imaging, February 2014
DOI 10.1007/s00259-013-2677-3
Pubmed ID
Authors

Samer Ezziddin, Feras Khalaf, Maria Vanezi, Torjan Haslerud, Karin Mayer, Abdullah Al Zreiqat, Winfried Willinek, Hans-Jürgen Biersack, Amir Sabet

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 87 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Mexico 1 1%
Italy 1 1%
Brazil 1 1%
Unknown 84 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 16 18%
Student > Master 12 14%
Student > Doctoral Student 10 11%
Student > Bachelor 5 6%
Other 5 6%
Other 17 20%
Unknown 22 25%
Readers by discipline Count As %
Medicine and Dentistry 44 51%
Agricultural and Biological Sciences 4 5%
Nursing and Health Professions 4 5%
Physics and Astronomy 4 5%
Pharmacology, Toxicology and Pharmaceutical Science 1 1%
Other 4 5%
Unknown 26 30%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 September 2023.
All research outputs
#2,714,030
of 24,413,320 outputs
Outputs from European Journal of Nuclear Medicine and Molecular Imaging
#214
of 3,396 outputs
Outputs of similar age
#32,195
of 317,154 outputs
Outputs of similar age from European Journal of Nuclear Medicine and Molecular Imaging
#2
of 50 outputs
Altmetric has tracked 24,413,320 research outputs across all sources so far. Compared to these this one has done well and is in the 88th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,396 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.2. This one has done particularly well, scoring higher than 93% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 317,154 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 89% of its contemporaries.
We're also able to compare this research output to 50 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.